The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma ; volume:14 ; number:1 ; day:20 ; month:7 ; year:2023 ; pages:1-15 ; date:12.2023
Nature Communications ; 14, Heft 1 (20.7.2023), 1-15, 12.2023
- Creator
-
Smith, Philip
Bradley, Thomas
Gavarró, Lena Morrill
Goranova, Teodora
Ennis, Darren P.
Mirza, Hasan B.
Silva, Dilrini De
Piskorz, Anna M.
Sauer, Carolin M.
Al-Khalidi, Sarwah
Funingana, Ionut-Gabriel
Reinius, Marika A. V.
Giannone, Gaia
Lewsley, Liz-Anne
Stobo, Jamie
McQueen, John
Bryson, Gareth
Eldridge, Matthew
Macintyre, Geoff
Markowetz, Florian
Brenton, James D.
McNeish, Iain A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-023-39867-7
- URN
-
urn:nbn:de:101:1-2024020210521256339760
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Smith, Philip
- Bradley, Thomas
- Gavarró, Lena Morrill
- Goranova, Teodora
- Ennis, Darren P.
- Mirza, Hasan B.
- Silva, Dilrini De
- Piskorz, Anna M.
- Sauer, Carolin M.
- Al-Khalidi, Sarwah
- Funingana, Ionut-Gabriel
- Reinius, Marika A. V.
- Giannone, Gaia
- Lewsley, Liz-Anne
- Stobo, Jamie
- McQueen, John
- Bryson, Gareth
- Eldridge, Matthew
- Macintyre, Geoff
- Markowetz, Florian
- Brenton, James D.
- McNeish, Iain A.
- SpringerLink (Online service)
Other Objects (12)
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
High-grade serous ovarian cancer: the clone wars
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
Principles of dormancy evident in high-grade serous ovarian cancer
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
High-grade serous ovarian cancer: the clone wars
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer
Principles of dormancy evident in high-grade serous ovarian cancer
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer
Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma
Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
High-grade serous ovarian cancer: the clone wars
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication
High-grade serous carcinoma with discordant p53 signature: report of a case with new insight regarding high-grade serous carcinogenesis
First-Line Management of Advanced High-Grade Serous Ovarian Cancer
PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
Tumor Evolution and Heterogeneity in High-Grade Serous Ovarian Cancer